Biolife Solutions Share Price Today
(NASDAQ: BLFS)

Name: Biolife Solutions Share Price Today (NASDAQ: BLFS) - Biolife Solutions Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Biolife Solutions share price is $26.25 & ₹2,282.94 as on 6 Mar 2025, 2.30 'hrs' IST

$26.25

▲

1.41

(5.68%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Biolife Solutions share price in Dollar and Rupees. Guide to invest in Biolife Solutions stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Biolife Solutions, along with analyst recommendations, forecasts, and comprehensive financials.

Biolife Solutions share price movements

Today's Low: $24.62
Today's High: $26.35
$26.25
6.21%
Downside
Day's Volatility :6.57%
Upside
0.38%
52 Weeks Low: $14.84
52 Weeks High: $29.55
$26.25
43.47%
Downside
52 Weeks Volatility :49.77%
Upside
11.15%

Biolife Solutions (BLFS) Returns

Period	Biolife Solutions, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	4.25%	3.7%	0.0%
6 Months	6.15%	-2.8%	0.0%
1 Year	49.83%	2.5%	0.0%
3 Years	11.04%	12.9%	-11.6%

Biolife Solutions (BLFS) Key Statistics

in dollars & INR

Previous Close	$24.84
Open	$24.87
Today's High	$26.35
Today's Low	$24.62
Market Capitalization	$1.2B
Today's Volume	$494.3K
52 Week High	$29.545
52 Week Low	$14.84
Revenue TTM	$147.0M
EBITDA	$-28.0M
Earnings Per Share (EPS)	$-0.25
Profit Margin	-31.32%
Quarterly Earnings Growth YOY	6.4%
Return On Equity TTM	-15.04%

How to invest in Biolife Solutions Stock (BLFS) from India?

It is very easy for Indian residents to invest directly in Biolife Solutions from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biolife Solutions stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biolife Solutions or BLFS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biolife Solutions or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biolife Solutions shares which would translate to 0.033 fractional shares of Biolife Solutions as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biolife Solutions, in just a few clicks!

Returns in Biolife Solutions (BLFS) for Indian investors in Rupees

The Biolife Solutions stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Biolife Solutions investment value today

Current value as on today

₹1,54,778

Returns

₹54,778

(+54.78%)

Returns from Biolife Solutions Stock

₹49,829 (+49.83%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Biolife Solutions (BLFS)

-33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Biolife Solutions Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Biolife Solutions

Casdin Capital, LLC
18.77%
BlackRock Inc
12.08%
Amvescap Plc.
6.98%
Vanguard Group Inc
6.11%
Fred Alger Management, LLC
3.44%
State Street Corp
3.17%

Analyst Recommendation on Biolife Solutions

Buy

86%Buy

13%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Biolife Solutions(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Biolife Solutions Stock (BLFS)

What analysts predicted

Upside of 18.1%

Target:

$31.00

Current:

$26.25

Insights on Biolife Solutions Stock (Ticker Symbol: BLFS)

Price Movement
In the last 7 days, BLFS stock has moved up by 11.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 28.32M → 30.57M (in $), with an average increase of 7.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -20.71M → -1.70M (in $), with an average increase of 1116.6% per quarter
BLFS vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 87.9% return, outperforming this stock by 78.5%

BLFS Biolife Solutions Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$27.4M	↑ 38.64%
Net Income	$11.1M	↑ 238.7%
Net Profit Margin	40.42%	↑ 23.88%

	FY20	Y/Y Change
Revenue	$48.1M	↑ 75.69%
Net Income	$2.7M	↓ 75.89%
Net Profit Margin	5.55%	↓ 34.87%

	FY21	Y/Y Change
Revenue	$119.2M	↑ 147.79%
Net Income	$-8.4M	↓ 414.32%
Net Profit Margin	-7.04%	↓ 12.59%

	FY22	Y/Y Change
Revenue	$161.8M	↑ 35.75%
Net Income	$-139.8M	↑ 1567.72%
Net Profit Margin	-86.43%	↓ 79.39%

	FY23	Y/Y Change
Revenue	$143.3M	↓ 11.43%
Net Income	$-66.4M	↓ 52.49%
Net Profit Margin	-46.36%	↑ 40.07%

	FY24	Y/Y Change
Revenue	$82.3M	↓ 42.59%
Net Income	$-20.2M	↓ 69.61%
Net Profit Margin	-24.54%	↑ 21.82%

	Q2 FY23	Q/Q Change
Revenue	$39.5M	↑ 4.79%
Net Income	$-10.2M	↓ 25.63%
Net Profit Margin	-25.82%	↑ 10.55%

	Q3 FY23	Q/Q Change
Revenue	$33.3M	↓ 15.64%
Net Income	$-29.1M	↑ 185.64%
Net Profit Margin	-87.41%	↓ 61.59%

	Q4 FY23	Q/Q Change
Revenue	$32.7M	↓ 1.79%
Net Income	$-13.4M	↓ 54.06%
Net Profit Margin	-40.89%	↑ 46.52%

	Q1 FY24	Q/Q Change
Revenue	$31.7M	↓ 3.07%
Net Income	$-10.2M	↓ 23.63%
Net Profit Margin	-32.22%	↑ 8.67%

	Q2 FY24	Q/Q Change
Revenue	$28.3M	↓ 10.71%
Net Income	$-20.7M	↑ 102.71%
Net Profit Margin	-73.14%	↓ 40.92%

	Q3 FY24	Q/Q Change
Revenue	$30.6M	↑ 7.92%
Net Income	$-1.7M	↓ 91.78%
Net Profit Margin	-5.57%	↑ 67.57%

	FY19	Y/Y Change
Profit	$18.5M	↑ 36.88%

	FY20	Y/Y Change
Profit	$27.4M	↑ 48.23%

	FY21	Y/Y Change
Profit	$37.7M	↑ 37.56%

	FY22	Y/Y Change
Profit	$53.8M	↑ 42.58%

	FY23	Y/Y Change
Profit	$46.8M	↓ 13.14%

	FY24	Y/Y Change
Profit	$57.8M	↑ 23.53%

	Q2 FY23	Q/Q Change
Profit	$11.8M	↓ 15.86%

	Q3 FY23	Q/Q Change
Profit	$11.6M	↓ 1.38%

	Q4 FY23	Q/Q Change
Profit	$8.3M	↓ 28.44%

	Q1 FY24	Q/Q Change
Profit	$11.6M	↑ 39.72%

	Q2 FY24	Q/Q Change
Profit	$14.9M	↑ 27.87%

	Q3 FY24	Q/Q Change
Profit	$21.8M	↑ 46.42%

	FY19	Y/Y Change
Operating Cash Flow	$1.2M	↓ 48.34%
Investing Cash Flow	$-27.0M	↑ 315.66%
Financing Cash Flow	$1.6M	↓ 94.33%

	FY20	Y/Y Change
Operating Cash Flow	$6.5M	↑ 437.1%
Investing Cash Flow	$-23.7M	↓ 12.17%
Financing Cash Flow	$101.2M	↑ 6242.36%

	FY21	Y/Y Change
Operating Cash Flow	$-4.8M	↓ 174.23%
Investing Cash Flow	$-12.6M	↓ 46.73%
Financing Cash Flow	$-2.8M	↓ 102.74%

	FY22	Y/Y Change
Operating Cash Flow	$-8.5M	↑ 75.54%
Investing Cash Flow	$-58.1M	↑ 359.71%
Financing Cash Flow	$16.3M	↓ 687.37%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-7.7M	↑ 184.59%
Investing Cash Flow	$9.3M	↑ 217.57%
Financing Cash Flow	$704.0K	↓ 225.27%

Biolife Solutions Technicals Summary

Sell

Neutral

Buy

Biolife Solutions is currently in a neutral trading position according to technical analysis indicators.

Biolife Solutions (BLFS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biolife Solutions, Inc.	-0.3%	6.15%	49.83%	11.04%	108.5%
Intuitive Surgical, Inc.	-2.01%	19.16%	46.34%	94.07%	233.7%
Alcon Ag	3.44%	0.33%	10.46%	30.15%	67.23%
Resmed Inc.	-6.92%	-8.56%	21.46%	-9.48%	44.87%
Becton, Dickinson And Company	-7.55%	-3.91%	-4.87%	-18.81%	-2.89%
Cooper Companies Inc., The	-4.17%	-14.24%	-10.35%	-8.95%	15.06%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biolife Solutions, Inc.	NA	NA	65.38	-0.03	-0.15	-0.06	NA	7.48
Intuitive Surgical, Inc.	88.57	88.57	3.92	8.06	0.16	0.09	NA	46.08
Alcon Ag	45.84	45.84	2.88	3.26	0.05	0.03	0.0	43.58
Resmed Inc.	27.56	27.56	1.52	9.47	0.26	0.14	0.01	35.77
Becton, Dickinson And Company	38.47	38.47	1.04	14.42	0.07	0.04	0.02	87.78
Cooper Companies Inc., The	46.74	46.74	9.59	3.98	0.05	0.04	NA	40.5

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biolife Solutions, Inc.	Buy	$1.2B	108.5%	NA	-31.32%
Intuitive Surgical, Inc.	Buy	$199.0B	233.7%	88.57	27.81%
Alcon Ag	Buy	$45.8B	67.23%	45.84	10.27%
Resmed Inc.	Buy	$34.0B	44.87%	27.56	25.35%
Becton, Dickinson And Company	Buy	$64.4B	-2.89%	38.47	8.37%
Cooper Companies Inc., The	Buy	$18.1B	15.06%	46.74	10.07%

About Biolife Solutions

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Organization	Biolife Solutions
Employees	0
CEO	Mr. Roderick de Greef
Industry	Health Technology

Management People of Biolife Solutions

Name	Title
Mr. Roderick de Greef	CEO & Chairman
Mr. Troy Wichterman CPA	Chief Financial Officer
Ms. Karen Foster	Chief Quality & Operations Officer
Dr. Aby J. Mathew Ph.D.	Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer
Mr. Sean Werner Ph.D.	Chief Technology Officer
Mr. Todd Berard	Chief Commercial Officer
Ms. Sarah Aebersold J.D.	Chief Human Resources Officer

Important FAQs about investing in BLFS Stock from India :

What is Biolife Solutions share price today?

Biolife Solutions share price today stands at $26.25, Open: $24.87 ; Previous Close: $24.84 ; High: $26.35 ; Low: $24.62 ; 52 Week High: $29.55 ; 52 Week Low: $14.84.

The stock opens at $24.87, after a previous close of $24.84. The stock reached a daily high of $26.35 and a low of $24.62, with a 52-week high of $29.55 and a 52-week low of $14.84.

Can Indians buy Biolife Solutions shares?

Yes, Indians can invest in the Biolife Solutions (BLFS) from India.

With INDmoney, you can buy Biolife Solutions at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Biolife Solutions at zero transaction cost.

How can I buy Biolife Solutions shares from India?

It is very easy to buy Biolife Solutions from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biolife Solutions (BLFS) be purchased?

Yes, you can buy fractional shares of Biolife Solutions with INDmoney app.

What are the documents required to start investing in Biolife Solutions stocks?

To start investing in Biolife Solutions, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.